You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fluoromisonidazole

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

Recruiting
  • Brain Cancer
  • [18F]fluoro-2-deoxy-D-glucose (FDG)
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 3, 2023

Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Recruiting
  • Radioembolization
  • +3 more
  • 18F-Fluoromisonidazole PET
  • Ankara, Turkey
    Ankara University
Sep 7, 2023

Idiopathic Pulmonary Fibrosis Trial in Dijon (FMISO-PET Protocol)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • FMISO-PET Protocol
  • Dijon, France
    Chu Dijon Bourgogne
Jul 5, 2022

Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brain Metastases
  • Magnetic Resonance Imaging (MRI)
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 10, 2023

Malignant Brain Tumor Trial in Portland (¹8F-Fluoromisonidazole, Computed Tomography, Magnetic Resonance Imaging)

Recruiting
  • Malignant Brain Neoplasm
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 19, 2022

Hepatocellular Carcinoma Trial in Birmingham (FMISO)

Terminated
Has Results
  • Hepatocellular Carcinoma
  • Birmingham, Alabama
    UAB Advanced Imaging Facility
Feb 15, 2021

Nasopharyngeal Carcinoma Trial in Singapore ((18)F-fluoromisonidazole (FMISO))

Completed
  • Nasopharyngeal Carcinoma
  • (18)F-fluoromisonidazole (FMISO)
  • Singapore, Singapore
  • +1 more
Aug 9, 2021

BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma Trial in

Recruiting
  • BCLC Stage A Hepatocellular Carcinoma
  • +3 more
  • 18F-Fluoromisonidazole
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
May 25, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Little Rock (18F-MISO)

Withdrawn
  • Squamous Cell Carcinoma of the Head and Neck
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Aug 17, 2021

Head and Neck Tumors, Recurrence Tumor Trial in Berlin (Moderate whole body hyperthermia using water-filtered IR-A-radiation)

Completed
  • Head and Neck Neoplasms
  • Recurrence Tumor
  • Moderate whole body hyperthermia using water-filtered IR-A-radiation
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
May 4, 2020

Recurrent Glioblastoma Trial in Philadelphia (biological, drug, radiation)

Terminated
  • Recurrent Glioblastoma
  • [18F]fluoromisonidazole
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 13, 2020

Esophageal Cancer Trial in Salt Lake City (Radiation, FMISO PET CT)

Recruiting
  • Esophageal Cancer
  • Radiation
  • FMISO PET CT
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 10, 2022

Head and Neck Squamous Cell Carcinoma Trial in Delhi (DE-HyART, Standard Arm, Cisplatin injection)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • DE-HyART
  • +3 more
  • Delhi, India
    Rajiv Gandhi Cancer Institute and Research Centre
Oct 20, 2023

Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell

Active, not recruiting
  • Stage III Lung Non-Small Cell Cancer AJCC v7
  • +2 more
  • Palo Alto, California
  • +30 more
Apr 28, 2021

Head Neck Cancer, Head and Neck Carcinoma, Head and Neck Tumors Trial in United States (diagnostic test, radiation, drug)

Recruiting
  • Head and Neck Cancer
  • +3 more
  • 18F-FMISO PET/CT scan
  • +2 more
  • Basking Ridge, New Jersey
  • +5 more
Sep 15, 2022

Adult Liver Carcinoma, Liver Cirrhosis Trial in Palo Alto (drug, procedure, diagnostic test)

Completed
Has Results
  • Adult Liver Carcinoma
  • Liver Cirrhosis
  • Palo Alto, California
    VA Palo Alto Healthcare System
May 1, 2019

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (FMISO, MRI, PET)

Completed
Has Results
  • Adult Giant Cell Glioblastoma
  • +2 more
  • Birmingham, Alabama
  • +13 more
Mar 14, 2019

Tumors, Benign, Tumors, Malignant Trial in Lebanon (OxyChip)

Terminated
  • Neoplasms, Benign
  • Neoplasms, Malignant
  • OxyChip
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jan 4, 2023

Triple Negative Breast Cancer Trial in Birmingham ([18F]FMISO-PET with contrast-enhanced MRI)

Not yet recruiting
  • Triple Negative Breast Cancer
  • [18F]FMISO-PET with contrast-enhanced MRI
  • Birmingham, Alabama
    UAB
Nov 15, 2022

Head Neck Cancer Trial in United States (fluorine-18-labeled fluoro-misonidazole (18F-FMISO), 18F-FMISO PET scan, MRI)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • fluorine-18-labeled fluoro-misonidazole (18F-FMISO)
  • +3 more
  • Basking Ridge, New Jersey
  • +4 more
Jul 8, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Cetuximab, Stereotactic radiosurgery)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Feb 10, 2022

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging

Not yet recruiting
  • Head and Neck Cancer
  • +3 more
  • [18F]MISO-PET/CT
  • (no location specified)
Oct 29, 2023

Malignant Glioma Trial in Las Palmas, Madrid (drug, procedure, device, radiation)

Terminated
  • Malignant Glioma
  • Las Palmas, Spain
  • +1 more
Aug 23, 2018

Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma Trial in Seattle

Terminated
Has Results
  • Recurrent Adult Soft Tissue Sarcoma
  • +4 more
  • fludeoxyglucose F 18
  • +4 more
  • Seattle, Washington
  • +1 more
Oct 17, 2017